Termite study
A study of the processes that termites use to break down plant cell walls could provide new enzymatic pretreatment processes for the production of biofuels.
A study of the processes that termites use to break down plant cell walls could provide new enzymatic pretreatment processes for the production of biofuels.
Termites are highly effective at degrading plant biomass including lignin but the process by which they do this is still not well understood. A study published in Biotechnology for Biofuels,1 has investigated the structural modification caused by termites in the lignin biomolecular assembly in softwood tissues crucial for cell-wall degradation. Termite-digested and native softwood tissues were compared using 13C crosspolarization magic angle spinning and nuclear magnetic resonance spectroscopy, Flash pyrolysis with gas chromatography–mass spectrometry (Py-GC–MS), and Py-GC–MS in the presence of tetramethylammonium hydroxide (Py-TMAH)-GC–MS.
Spectroscopic analysis, confirmed by the Py-GC–MS data indicated dehydroxylation and modification of selective intermonomer side-chain linkages. Moreover, Py-TMAH-GC–MS analysis showed significant differences in the product distribution, which the researchers report strongly suggests that the structural modification in lignin could be associated with the formation of additional condensed interunit linkages. The study concluded that these results provide insight into lignin-unlocking mechanisms for understanding plant cell-wall deconstruction, which could be useful in the development of new processes mimicking the termite system for biochemical conversion of lignocellulosic biomass to fuels and chemicals.
1. J. Ke, Biotechnology for Biofuels, 4(17) (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
